Evidence map›Paper›PMID 36791099›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.

Changying Guo, Karla F Meza-Sosa, David Valle-Garcia, Guomeng Zhao, Kun Gao, Liting Yu, Hongying Zhang, Yeqing Chen, Liang Sun, Shira Rockowitz and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. The oncoprotein SET promotes serine-derived one-carbon metabolism by regulating SHMT2 enzymatic activity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Changying GuoCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.
Karla F Meza-SosaProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-0095-2357
David Valle-GarciaDivision of Newborn Medicine and Epigenetics Program, Boston Children's Hospital, Boston, MA 02115.
Guomeng ZhaoChina Pharmaceutical University, Nanjing 211198, China.
Kun GaoChina Pharmaceutical University, Nanjing 211198, China.
Liting YuChina Pharmaceutical University, Nanjing 211198, China.
Hongying ZhangChina Pharmaceutical University, Nanjing 211198, China.
Yeqing ChenYing Wu College of Computing, New Jersey Institute of Technology, Newark, NJ 07102.
Liang SunResearch Computing, Department of Information Technology, Boston Children's Hospital, Boston, MA 02115.
Shira RockowitzResearch Computing, Department of Information Technology, Boston Children's Hospital, Boston, MA 02115.
Shouyu WangJiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China.
Sheng JiangChina Pharmaceutical University, Nanjing 211198, China.
Judy LiebermanProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.ORCID 0000-0002-6200-4715
Boston Children's Hospital · USChina Pharmaceutical University · CNNanjing University · CNNew Jersey Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SET is a multifunctional histone-binding oncoprotein that regulates transcription by an unclear mechanism. Here we show that SET enhances estrogen-dependent transcription. SET knockdown abrogates transcription of estrogen-responsive genes and their enhancer RNAs. In response to 17β-estradiol (E2), SET binds to the estrogen receptor α (ERα) and is recruited to ERα-bound enhancers and promoters at estrogen response elements (EREs). SET functions as a histone H2 chaperone that dynamically associates with H2A.Z via its acidic C-terminal domain and promotes H2A.Z incorporation, ERα, MLL1, and KDM3A loading and modulates histone methylation at EREs. SET depletion diminishes recruitment of condensin complexes to EREs and impairs E2-dependent enhancer-promoter looping. Thus, SET boosts E2-induced gene expression by establishing an active chromatin structure at ERα-bound enhancers and promoters, which is essential for transcriptional activation.

Indexed as

ChromatinHistonesCell Line, TumorEstradiolEstrogen Receptor alphaEstrogensOncogene ProteinsTranscription, GeneticChromatinEstradiolEstrogen Receptor alphaEstrogensHistonesOncogene Proteinsbreast cancerestrogenhistone chaperoneSETtranscriptional activation

Identifiers

PMID36791099
PMCPMC9974495
OpenAlexW4320856676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.